Td Private Client Wealth LLC Viridian Therapeutics, Inc.\De Call Options Transaction History
Td Private Client Wealth LLC
- $3.63 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VRDN
# of Institutions
202Shares Held
79.2MCall Options Held
477KPut Options Held
917K-
Black Rock Inc. New York, NY4.77MShares$63.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.6MShares$61.4 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.52MShares$60.5 Million3.82% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$51.9 Million12.28% of portfolio
-
State Street Corp Boston, MA3.52MShares$47.1 Million0.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $533M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...